Use of single molecule sequencing for comparative genomics of an environmental and a clinical isolate of  ribotype 078 by unknown
RESEARCH ARTICLE Open Access
Use of single molecule sequencing for
comparative genomics of an environmental
and a clinical isolate of Clostridium difficile
ribotype 078
Katherine R. Hargreaves1,2* , Anisha M. Thanki1, Bethany R. Jose1, Marco R. Oggioni3 and Martha R. J. Clokie1*
Abstract
Background: How the pathogen Clostridium difficile might survive, evolve and be transferred between reservoirs
within the natural environment is poorly understood. Some ribotypes are found both in clinical and environmental
settings. Whether these strains are distinct from each another and evolve in the specific environments is not
established. The possession of a highly mobile genome has contributed to the genetic diversity and ongoing evolution
of C. difficile. Interpretations of genetic diversity have been limited by fragmented assemblies resulting from short-read
length sequencing approaches and by a limited understanding of epigenetic regulation of diversity. To address this,
single molecule real time (SMRT) sequencing was used in this study as it produces high quality genome sequences,
with resolution of repeat regions (including those found in mobile elements) and can generate data to determine
methylation modifications across the sequence (the methylome).
Results: Chromosomal rearrangements and ribosomal operon duplications were observed in both genomes. The
rearrangements occurred at insertion sites within two mobile genetic elements (MGEs), Tn6164 and Tn6293, present
only in the M120 and CD105HS27 genomes, respectively. The gene content of these two transposons differ
considerably which could impact upon horizontal gene transfer; differences include CDSs encoding methylases and a
conjugative prophage only in Tn6164. To investigate mechanisms which could affect MGE transfer, the methylome,
restriction modification (RM) and the CRISPR/Cas systems were characterised for each strain. Notably, the
environmental isolate, CD105HS27, does not share a consensus motif for m4C methylation, but has one additional
spacer when compared to the clinical isolate M120.
Conclusions: These findings show key differences between the two strains in terms of their genetic capacity for MGE
transfer. The carriage of horizontally transferred genes appear to have genome wide effects based on two different
methylation patterns. The CRISPR/Cas system appears active although perhaps slow to evolve. Data suggests that both
mechanisms are functional and impact upon horizontal gene transfer and genome evolution within C. difficile.
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Background
Clostridium difficile (reclassified as Clostrioides difficile
[1]) is an enteric pathogenic bacterium that can cause
symptomatic disease, which ranges in severity from fever
and diarrhoea to the development of pseudomembran-
ous colitis and toxic megacolon [2]. Clostridium difficile
infection (CDI) occurs following antibiotic treatment as
new ecological niches become available upon disruption
of the normal microbiota [3]. CDI may arise from
ingested endospores transmitted via the faecal oral route,
or from vegetative cells already present in the patient, as
the bacterium can be asymptomatically carried in adults
and children [4]. CDI may also be contracted outside the
hospital setting [4], and C. difficile has been isolated from
food products [4–6], on surfaces around the home [7]
and from swimming pools [7]. It has also been isolated
from the natural environment including river water, soils,
sea water and estuarine sediments [7–10]. The presence
of C. difficile at these sites may be due to contamination
with sewage or agricultural run-off, yet bacteria from
these locations could be re-introduced to the food chain,
for example via contaminated shellfish or seafood [11,
12], and they have been implicated in the infection of
marine mammals [13].
The movement of C. difficile between reservoirs is par-
ticularly pertinent for isolates of the PCR ribotype 078
(R078). This is an epidemic strain, first identified in live-
stock and subsequently in clinics across Europe [14]. Al-
though pathogenic, it is not clear quite how much
virulence versus strain fitness shapes which strains come
to prominence in the hospital environment [15, 16].
R078 strains form a lineage divergent from other major
ribotypes [17], as also determined via multilocus sequence
typing (MLST) analysis [18, 19] and core genome phyloge-
nies [20, 21]. Previously, we isolated a R078 strain,
CD105HS27, from estuarine sediment [9] and sequenced
its genome using Illumina HiSeq 2000 generating a
draft assembly [22]. The carriage of transposon Tn6293
(previously unnamed) and the absence of Tn6164 was
confirmed in this study from the results of the Single
Molecular Real Time (SMRT) sequencing. The accessory
gene content in C. difficile as a species is high relative to
the size of its core genome [23], and it is characterised
by multiple mobile genetic elements which include
transposons, integrated conjugative elements, plasmids
and prophages (for recent reviews see [23–25]). The
acquisition of antibiotic resistance and novel virulence
factors are thought to drive C. difficile strain pathogen
evolution [26], but its ecology outside of the human
host is little understood.
Recently, SMRT technology has been applied to
sequence C. difficile genomes, exploiting the long read
data to determine chromosomal structure, mobile genetic
content and methylation patterns [27–31]. The re-
sequencing of previously analysed strain CD630 showed
differences in its ribosomal operon, transposon and tRNA
content [28, 31]. In this study we first determined if re-
sequencing the reference strain M120 (R078) using SMRT
would reveal differences in the chromosomal architecture.
Next, we compared SMRT generated genome sequences
of M120 with CD105HS27 in order to gain a better under-
standing of the differences between an environmental iso-
late and a clinical strain. To date, SMRT has not been
applied to isolates of R078. In addition to analysing the
genomic data, we compared methylation patterns across
the genome. Due to the fact that the CRISPR/Cas system
also can provide immunity to invading DNA elements, we
assessed its potential to target MGEs for each strain. In
both cases, understanding mechanisms that govern hori-
zontal gene transfer in C. difficile provides insight into the
genome evolution of this pathogen.
Results and discussion
Genome features of M120 and CD105HS27
The two genome assemblies generated using SMRT are
in near-complete condition; the genome of M120 is
4,082,634 bp with an average coverage of 16.3×, an aver-
age 28.73% GC content, and is comprised of two contigs
of 4,069,609 bp and 13,024 bp in length. The total se-
quence for CD105HS27 is 4,122,476 bp, with an overall
coverage of 15.75× and an average 29.15% GC content,
and consists of five contigs of 3,462,540 bp, 339,877 bp,
174,028 bp, 146,675 bp and 1156 bp, respectively.
Both assemblies were compared to the reference genome
of M120, which is a single chromosome 4,047,729 bp in
length with an average 28.76% GC content. The 13,024 bp
size contig contains a set of 5S, 16S and 23S rRNA genes
and 19 tRNA genes, and has duplicated region encoding
an identical tRNA (Alanine) and 16S rRNA gene (dot plot
data not shown), in addition to predicted CDSs encoding
glycosyl transferases, DNA polymerase subunit and recom-
bination protein RecR. The relative coverage of this contig
is on average 1.3× (see Fig. 1). To determine whether this
contig represents a sequence mobilization event and a low
copy number requires experimental investigation.
Annotation of the re-sequenced M120 genome identi-
fied 3541 CDSs, 101 tRNAs and 39 rRNAs; this is consist-
ent with the reference genome, but includes an additional
15 tRNAs and 7 rRNA genes. Similar observations were
seen in a SMRT sequenced genome of CD630Δerm with
additional tRNA and rRNA genes located in a novel ~5
kbp insertion [28]. This was attributed to adaption during
laboratory culture as extra ribosomal gene operon copies
have been shown to affect fitness in E. coli with regards to
nutrient availability [32]. Furthermore, recombination
events have been suggested as a mechanism for generating
the diversity of ribotypes in C. difficile [33].
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The genome of CD105HS27 has 3598 CDSs, 93 tRNA
and 47 rRNA genes. The chromosome breaks are
located in regions encoding ribosomal genes, which ap-
pear to have undergone duplication events across the
genome. The application of SMRT can also improve the
assembly of other regions containing repeat sequences.
For example, previously, toxin gene carriage had been
confirmed by PCR for CD105HS27 [9], but an Illumina
generated draft genome assembly of its genome resulted
in fragmented versions of tcdA and tcdB [22]. Here,
these genes have been resolved fully. CD105H27 has 79
CDSs that are not present in M120, most of which are
encoded on Tn6293, In contrast, M120 has 103 CDSs
that are not present in CD105HS27, of which 102 are
encoded on Tn6164. The predicted genetic content of
these two transposons suggests that they may be conjuga-
tive transposons although this has yet to be demonstrated
experimentally. Therefore, these should be re-termed as
putative conjugative transposons CTn6164 and CTn6293.
Tn6164 is a large (~100 kbp) element that appears to be
two MGEs including a prophage region which shares
similarity to the Streptoccocus conjugative phage Φ1207. 3
[34]. Φ1207. 3 has been demonstrated to transfer between
strains via conjugation and was originally annotated as a
conjugative transposon [35] but contains conserved phage
genes including those predicted to encode terminases,
capsid, tail and holin proteins leading to its re-designation
as a conjugative prophage [36]. Prophages transmitting via
conjugation appear rarely in the literature (e.g. [37]).
Whether these prophages also transfer via conjugation
has not been established, however their discovery suggests
that this mechanism may occur more widely than previ-
ously known.
The two genomes are related, sharing an average nu-
cleotide identity of 99.98% based on the whole genome
sequence (following the method described in [38]).
Alignment of the whole genomes using MAUVE and its
SNP (Single Nucleotide Polymorphism) detection tool
showed that the aligned sequences differed in 85 posi-
tions by single nucleotide changes. Further comparison
Fig. 1 Genome features and comparisons of M120 and CD105HS27. Comparison between M120 reference genome (top), M120 sequenced with
SMRT (middle) and CD105HS27 (below). The genomes are connected by regions indicating nucleotide (nt) sequence similarity with notable
genomic features annotated at locations along the genome including the PaLoc (Pathogenicity Locus), C. difficile binary toxin (CDT) genes, C.
difficile sigK intervening (skinCd) element, flagella gene region 1 (F1) and annotated transposons. The GC% is provided for all three genomes alongside
the coverage and methylation modifications for N4-methylcytosine (m4C), N6-methyladenine (m6A) and undetermined modified bases. Boxes highlight
the different methylation patterns observed across each of the unique transposons
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of the two genomes via BLASTn (Fig. 1) and within a
dotplot (Fig. 2) revealed extensive sequence similarity
between the two strains, with exceptions of two large
indel (insertion-deletion) regions (~100 kbp) that carry
the putative CTns Tn6164 and Tn6123, the movement
of Tn6190, and inversion rearrangements. Use of SMRT
has previously shown major chromosomal rearrange-
ments from resequencing the genome of strain CD630
in addition to duplication of ribosomal gene operons
[28, 30]. One mechanism for these rearrangements are
the movement of the MGEs, as seen in the mutant
CD630Δerm, where the re-mobilisation of transposon
CTn5 led to the inversion of the genome sequence
[28]. What affect such chromosomal re-engineering
has on the physiology of the cell in terms of gene ex-
pression is not known, but may be significant as has
been described for the control of DNA elements from
the chromosome in the regulation of diverse bacterial
processes [39].
In silico typing of M120 and CD105HS27
In C. difficile, ribotyping is one of the main methods
used to categorise strains. In silico ribotyping was
performed to assess the outcomes from the SMRT gen-
erated genomes and to explain how the duplication
events affect the ribotypes profile. As expected from the
different numbers of total rRNA genes, the two profiles
differ, with 11 bands predicted from M120 reference, 12
from M120 SMRT and 16 from CD105HS27 (Additional
file 1: Table S1). The profiles differ by duplication of
identical sized regions in addition to bands of different
lengths which may affect ribotypes assigned. While ribo-
somal gene regions assemble poorly in Illumina datasets,
the ability to generate near complete genomes using
Fig. 2 Dotplot of the two genome sequences with indel regions and chromosomal rearrangements. Pairwise comparison of the two nucleotide
sequences was performed using a dotplot matrix. The results show regions of shared sequence along the chromosomes (black line) and where
there are insertion-deletion (indel) events that result in no sequence similarity shared between the genomes (white gap). The two largest gaps
(~100 kbp each) correspond to the positions of the putative CTns, Tn6164 in M120 and Tn6123 in CD105HS27. The conserved but differently
positioned Tn6190 is shown also. The contigs for each genome are illustrated along the sides for each genome to show the chromosomal
rearrangements occur within the assembled contig boundaries
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SMRT technology show how ribosome operon duplica-
tion and recombination events could be tracked.
Another method used to type C. difficile is MLST
(multilocus sequence typing), a scheme that compares
the sequence data for seven conserved genes [40]. The
two isolate genomes were assigned to Sequence Type
(ST) 11, clade 5, which is consistent with previously
typed isolates of R078 [19, 40, 41]. The C. difficile MLST
tool also analysed additional key genes, such as toxins
Toxin A, Toxin B and the CDT and also genes that
encode for antibiotic resistance. The results confirmed
both M120 and CD105HS27 have wild type toxin genes
cdtAB and tcdB and a 39 bp deletion in tcdC which has
been characteristic of R078 isolates from its early identi-
fication [14]. Furthermore, tetM, predicted to encode a
ribosomal protection protein (CDM120_RS02595) carried
on Tn6190 in M120 [34], is absent in CD105HS27, which
has two copies of a variant tetM, that share 67% identity at
the aa level to that in M120.
Mobile genetic element content of M120 and CD105HS27
Like other isolates, those from R078 have been found to
carry different sets of MGEs which encode for predicted
virulence factors and antibiotic resistance [24, 25]. These
include the conjugative transposons related to those in
other strains of C. difficile; Tn6073 (CTn1-like), Tn6107
(CTn5-like) and CTn4 in the clinical R078 strain QCD-
23 M63 [42], as well as those more distantly related,
such as Tn6164 in the reference strain M120 [34].
Tn6164 is a composite MGE containing a prophage and
has several regions that originate from different bacterial
lineages [34]. This is considered likely to be a transposon
as it can excise and circularise, and carries genes encod-
ing products predicted to be involved in conjugation
[34]. While Tn6164 is characteristically associated with
R078 strains, not all R078 isolates carry it [34]. R078 iso-
lates also may harbour Tn6190 (previously termed
CTnCD3a [20]), a Tn916-related element that carries
the tetracycline resistance gene tetM [42], as well as
Tn6235 which carries aphA1, an aminoglycoside 3′-
phosphotransferase suggested to confer streptomycin re-
sistance [19]. M120 and CD105HS27 both have Tn6190,
but, as described previously, M120 has Tn6194 whereas
CD105HS27 does not. However, the environmental iso-
late does have a different large ~104 kbp element [22],
now assigned as Tn6293. Encoded on Tn6293 are sev-
eral genes with predicted functions that could potentially
enhance cell survival and growth, including homologs of
aadE (which confers aminoglycoside resistance [43]), a
LexA repressor (involved in the SOS response regulation
[44]) and 23S rRNA methyltransferase RlmN (that could
impact on cellular growth [45]). It has predicted transpo-
sases and conjugation transfer genes as well as homologs of
plasmid maintenance and replication protein encoding
genes; parA and parB, and repA, suggesting this MGE is
also a composite with several origins as determined for
other C. difficile transposons, Tn9194 and Tn6103 [34,
42]. Interestingly, the amino acid sequence of AadE was
100% identical to that of plasmid-carried aadE genes in
Campylobacter jejuni (YP_009079621) and Pediococcus
acidilactic (YP_001965484), and is present in several
Firmicutes sp. sequences from WGS projects, further
supporting prior observations that this resistance can
transmit between bacterial genera [46]. To determine
the carriage of Tn6293 in C. difficile, its sequence was
searched using BLASTn against C. difficile (taxid
1496) sequences. Homologous regions were found in
the genomes of three of the seven isolates that are re-
lated to M120 (Additional file 2: Table S2); E1 and
T5 (R126, human isolates) and NAP08 (R078, human
isolate) [21]. To determine its potential origin, the nt
sequence was searched against the NCBI nt/nr db. It
has similarity to regions in Eubacterium and Rumino-
coccus spp. genomes. The shared nt sequence
similarity is primarily located in genes whose pre-
dicted products are involved in genetic element mo-
bilisation and maintenance functions. These include a
serine recombinase (CD105HS27_00591), DNA bind-
ing and mobilization proteins (CD105HS27_00611
and CD105HS27_00612) and plasmid recombinase
(CD105HS27_00634). Both Eubacterium sp. and Rumino-
coccus sp. belong to the same order as C. difficile, the
Clostridiales, and the shared sequence similarity observed
supports previous findings of MGEs being exchanged
between these genera [25].
Both genomes carry a predicted R-type bacteriocin.
R-type bacteriocins resemble phage tail-like particles
(PTLPs) and have genes predicted to encode proteins
involved in structural roles for tail assembly. However,
they lack predicted capsid genes and thus are not a
complete virion particle. These bacteriocins, or PTLPs,
have been observed in culture supernatants of diverse
isolates [9, 47, 48], and been used either as typing
tools or to determine their use as alternative thera-
peutics [49, 50]. Due to the specificity required of
proteins that target the cell surface, obtaining se-
quence information from the genomes of clinically
relevant strains could aid in using a synthetic biology
approach for designer antimicrobials; this has been
demonstrated for the bacteriocin carried in a R027
isolate [51], with subsequent genetic modification for
enhancing its antimicrobial application [52].
It is not possible to conclude whether these strains
have transferred from the environment to the patients
or vice versa from the comparisons we have performed
here based on a sample size of two. However, the putative
origins of these CTns have been examined based on se-
quence homology. Tn6164 and Tn6293 are clearly distinct
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from one another, and to known elements in other bacterial
species. For example, for Tn6164, similarity to other se-
quences is split over the length of the transposon into at
least two major regions: the phage containing region is
most closely related to a single Clostridium difficile
genome Z31 (CP013196.1) based on a nt identity of 93%
covering 35% of its length. In the same region, the next
most closely related elements are found in the complete
genome of Thermoanaerobacter spp. (CP002210 and
CP000923.1) and a draft genome of Clostridium borni-
mense (GCA_000577895). Thermoanaeroacter strains
were originally isolated from anaerobic enrichments with
environmental samples from subsurface. C. bornimense is
a hydrogen producing Clostridium and this species does
not have an associated history with human infections, but
isolated from a laboratory bioreactor [53]. The second
region of the transposon has homology to Streptococcus
and Anaerococcus spp. In contrast, Tn6293 showcases
sequence similarity in multiple regions across its full
length to different bacterial genera including Ruminococ-
cus, Clostridium and Eubacterium spp. It is interesting
that the second region of homology in Tn6164 is to
pathogenic species. However, as this is based on few
sequences, it is not possible to conclusively state this has
been acquired while in clinics despite its absence from
CD105HS27 (and thus infer CD105HS27 has evolved
outside of clinics). Whether the two isolates have evolved
in isolation is one possibility. SNP analysis has been used
to track the transfer of strains across the world [54] and in
different reservoirs [19, 54], with estimated mutation
rates of 1–2 sites per year, suggesting that the number
of substitutions (n = 85) we observed here suggests
that these two isolates have evolved from one another
over some time. Increasing numbers of R078 genomes
will aid in determining the movement of strains from
clinics to the environment and vice versa, in addition
to how these strains further evolve when in different
reservoirs.
Methylome of R078 isolates
To establish genome-wide methylation patterns of the
two isolates, the profiles for methylation modifications
N4-methylcytosine (m4C) and N6-methyladenine (m6A)
were analysed from the SMRT data [55]. Methylation
(the addition of methyl groups to bases) in bacteria may
play a regulatory role in terms of gene expression [56],
but is also one way that DNA elements can exploit to
protect against their degradation by restriction modifica-
tion systems in the host cell [57]. Both strains M120 and
CD105HS27 show adenine methylation of the consensus
sequence CAAAAA with high efficiency of target methy-
lation (7484/7579, or 98.75% sites in M120 and 7469/
7559 or 98.8% in CD105HS27). This target specificity
had been previously assigned to the N6-adenine
methyltransferase named M.Cdi25 or Cdi630V (locus
tag CD630_27580, protein Id YP_001089271.1) of strain
CD630 [22] and is reported in the REBASE database
[58]. The respective methyltransferases of M120
(CDM120_RS14295, WP_003422891.1) and CD105HS27
(CD105HS27_02520) are identical and show a 98% iden-
tity (565/577) to the CD630 orthologue. Strain M120
showed signatures for a N4 modified cysteine ACGGC
methylation target (398/414) and a consensus sequence
CGGCNTGTGNNNNNNT was identified but with
unknown modified base calls (12/13). In REBASE, the
ACGGC target is assigned to two tandem methyl-
transferases of Tn6164, M1.CdiMORFAP (CDM120_
RS02255, WP_041160334.1) and M2.CdiMORFAP (CD
M120_RS02260, WP_041160335.1). No further modified
base was detected in strain CD105HS27. The finding
that methylation pattern of m4C GCCGT/ACGGC was
absent in CD105HS27 may be explained by the absence
of Tn6164 and both these two methyltransferases. In
contrast, both M120 and CD105HS27 encode CdiMOR-
FEP, a homolog of M.CdiG46II (amino acid identity of
565/577 (98%)) which is predicted to recognise CAA
AAA sites. Three further predicted methylases on
Tn6164 are present in M120 [34] and absent from
CD105HS27, as the latter lacks this mobile element.
While it was expected for the two Tn6164 m5C methyl-
transferases M.CdiMORFBP (CDM120_RS02360, WP_
041160353.1) and M.CdiMORFCP (CDM120_RS02725,
WP_041160386.1) to show no signature on the SMRT
dataset, we would have expected to identify a signature
for the putative m6A methyltransferase (CDM120_
RS02520, WP_000662263.1). The fact that no additional
adenine methylation pattern was detected could be due
to one of many reasons including target identity of this
enzyme and M.Cdi25/Cdi630V, lack of expression of the
enzyme in CD105HS27 or inappropriate annotation of
predicted CDSs.
Just as there are different sets of methylation genes
functional in C. difficile, strains carry genes encoding
multiple restriction enzymes [59]. It is of interest to note
that despite the fact that M120 and CD105HS27 are
highly related, they share only core genome methylation
systems as the adenine methylase above or the McrBC
system, as they do with the strain CD630. This is due to
the fact that the majority of methyltransferases are in
Tn6164 which is absent from CD105HS27. In addition
to methylation Restriction Modification (RM) systems,
MGEs have other defence systems against super-
infection [60]. Here, Tn6164 carries three putative meth-
ylase genes on the transposon region and two on the
prophage region of the element. The two sequenced
strains were also found to contain defence mechanisms
to combat RM systems, notably, Tn6190 carries ardA
which encodes ArdA, an anti-restriction protein for type
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I restriction systems [61]. Whether this system is active
remains to be determined, but evidently there are mul-
tiple mechanisms employed by MGE in C. difficile to be
maintained.
CRISPR/Cas system of M120 and CD105HS27
Immunity to phage infection can also be conferred via the
CRISPR (Clusters of Regularly Interspaced Palindromic
Repeats)/Cas system which works as an RNA based inter-
ference against invading DNA elements [62], but also may
act as regulatory machinery for other aspects of the cell
biology and genome evolution [63]. The function of the
CRISPR/Cas system depends on the action of CRISPR as-
sociated (Cas) proteins that are highly diverse in operons
across prokaryotes, and ultimately involves the processing
and matching of spacers to target DNA with its subse-
quent restriction [64]. It comprises of arrays that have
conserved direct repeat (DR) sequences that flank spa-
cer sequences. Spacers are homologous to phage or
plasmid sequences as have been incorporated into ar-
rays following unsuccessful past invasions, and in this
way they can provide information about past interac-
tions with such elements [65].
In this study, six CRISPR arrays and three cassettes of
Cas genes were identified in each genome. Two Cas
gene operons belonged to the I-B/TNeap group and
contained all gene components to be functionally
complete [64], and the third set comprised of cas6, cas7,
cas5 and cas3, but lacked cas1 and cas2. Multiple cas
sets within a single genome, of both complete and in-
complete operons, have been described previously in C.
difficile strains CD630 [66] and R20291, but it appears
unusual that these two isolates have two complete yet
distinct cassettes. The two complete sets are adjacent to
CRISPR arrays CRISPR 4 and CRISPR 5.
The six CRISPR arrays are conserved between the
two isolates. Five of the arrays have identical spacer
contents with 17 (CRISPR_1), 44 (CRISPR 2), 13
(CRISPR 3), 32 (CRISPR 5) and 9 (CRISPR 6) spacers.
The remaning array, CRISPR 4, has one additional spa-
cer in CD105HS27 than M120, with 39 and 38 spacers,
respectively (spacer number 12, indicated in by Add-
itional file 3: Table S5. by asterisk). Previously, we
showed that spacers targeted C. difficile phages [66].
Here, we searched spacers from the six arrays against
20 C. difficile phage genomes (Fig. 3, Additional file 4:
Table S3). Of the total 154 spacers present in both iso-
lates, 19 spacers have at least one identical match to a
phage sequence from 18 phages. Perfect matches were
identified between spacers and phage sequences from
all arrays, except CRISPR arrays 3 and 6. Spacers with
matches were located throughout the arrays, but dif-
fered with regards to location and type of phage (Fig. 3).
We focused on perfect matches as phages phiCDHM1,
phiCDHM19, phiCDHM14 and phiCDHM13 do not
produce lysis of either strain [22]. To identify matches
for the remaining spacers and to a wider range of DNA
sequences, we searched the viral and plasmid databases
in CRISPRTarget [67], the metaviromic datasets publi-
cally available on MetaVir [68] and C. difficile genomes
(Additional file 4: Table S3 and Additional file 5: Table
S4). We did not detect any perfect matches to the viro-
mic datasets, but identified matches for spacers from
all six CRISPR arrays to prophage and phage-like genes
in the C. difficile bacterial genomes (Fig. 4, Additional
file 3: Table S5). It has been found that CRISPR sys-
tems may also have regulatory roles in genomes [69].
To identify if there were spacers that matched to
genomic sequence, we searched the genome of
CD105HS27 and identified one perfect match for a
spacer in CRISPR 6. The protospacer sequence is lo-
cated in CD105HS27_02420, a gene encoding a puta-
tive carboxylase. This does not have either of the
previously identified CCT or CCA Protospacer Adja-
cent Motif (PAM) sequences [66] so whether this has
a functional role is unknown.
We see that in C. difficile, CRISPR arrays appear to
undergo horizontal exchange between strains via their
presence on MGEs, including prophage, plasmids and
the C. difficile sigK intervening (skinCd) element [18, 66].
In the genome of C. cellulolyticum H10, two CRISPR ar-
rays are proximal to a transposase gene which suggests
that recombination events could shift immunity profiles
via the introduction of novel arrays with new spacer
content [70]. Similarly in M120 and CD105S27, two of
the arrays, CRISPR 1 and CRISPR 2, are in proximity to
CDSs that suggest past integration events containing
either integrase or transposase domains. Whether these
genes still function and these regions are mobile is not
clear from annotation alone. However, these findings of
arrays on MGE and signatures of past integration
events nearby suggest that arrays could move following
genome insertion and excision events by a variety of
mechanisms.
Conclusions
SMRT technology has been used to generate near
complete genomes for two R078 strains, allowing the
comparison of clinical and environmental isolates. The
two genomes differ in chromosomal structure and
number of ribosomal operons. Additionally, the two ge-
nomes differ in the carriage of two transposons, Tn6164
in M120 and Tn6293 in CD105H27, which we suggest are
termed as putative conjugative transposons CTn6164 and
CTn6293.
The majority of unique genes are carried on the
two putative CTns and include predicted methyl-
ases. The methylome analysis for each genome
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suggests a vastly different methylation pattern with no
consensus m4C motif in CD105HS27 detected. This likely
impacts the immunity of each isolate to DNA elements in-
cluding phages, and to the type of HGT that may occur
for each. In contrast, their CRISPR/Cas systems are highly
similar with only one spacer different between the two.
Our findings support previous work that the CRISPR/Cas
and RM systems are not mutually exclusive [71], and show
this indeed appears to be the case in C. difficile.
Methods
Bacterial genomic DNA extraction
Bacterial genomic DNA (gDNA) extraction was per-
formed using 1 ml overnight culture from a single col-
ony grown in Brain Heart Infusion (BHI) broth (Oxoid,
UK). DNA was extracted using a Qiagen GenomicTip
500/G kit (Qiagen, UK) following the manufacturer’s
instructions. Pulsed Field Gel Electrophoresis was
performed to assess gDNA degradation, with 100 ul of
each sample separated on a 1% Agarose gel (Manufacturer
info) for 18 h at 6 V. Gels were stained with 10 ul of
ethidium bromide and visualised using UV G Box, Syn-
gene. Sample gDNA quantity and quality was measured
using by Qubit assay on a Qubit fluorometer (Life
Technologies, USA) according to the manufacturer’s in-
structions, and by measuring absorbance at 260 nm
and 280 nm using a Nanodrop Spectrophotometer
(Thermo Scientific, UK).
Genome sequencing and bioinformatics analysis
Genomic DNA sequencing using a SMRT Pacific
Biosciences platform was performed at the Centre for
Genomic Research, University of Liverpool. SMRTbell
libraries were prepared by Margaret A. Hughes with 3
SMRT cells used per library for sequencing. High quality
genome assemblies were generated using HGAP (Hierar-
chal Genome Assembly Processer) as part of the SMRT
Portal and methylation patterns detected. Contig structure
and plasmid identification was performed from dotplots
generated using Gepard [72].
Genomes were visualised using Artemis Genome
Browser [73]. Coverage was determined from alignment of
the corrected reads to the final assembly using BWA-SW
[74], and samtools for index and conversion of file formats
[75]. Coverage was assessed using Qualimap v.1.0 [76] and
coverage plots were generated using the Artemis DNA-
plotter perl script [77]. Genome annotation was per-
formed using PROKKA v1.7 [78], with a custom guide
database containing proteins from the reference genome
of M120 (accession NC_017174.1). RNA genes were pre-
dicted using RNAmmer v1.2 [79]. In silico ribotypes pro-
files were predicted using the oligonucleotide sequences
from Bidet et al. [80]. Shared gene content was identified
with blast + v2.2.28 using blast-all-v-all [81]. This publica-
tion made use of the Clostridium difficile Multi Locus
Sequence Typing website (http://pubmlst.org/cdifficile/)
developed by Keith Jolley and sited at the University of
Oxford [82]. The characterised C. difficile CD630 CTns
Fig. 3 CRISPR spacer content with perfect matches to C. difficile phages. Left. Positions of spacers for each array with matches to the 18 phages
(key coloured according to groups of medium myoviruses (MMs), long tailed myoviruses (LTMs), small myoviruses (SMVs) and siphoviruses (SVs)).
The arrays show clear differences in terms of protospacer content with spacers that match to multiple phages. Right. Histogram showing the
matches to protospacers in phage genes encoding portal, terminase, tape measure (TMP), tail fiber, cell wall hydrolase, repressor, anti-repressor,
DNA binding and hypothetical proteins in addition to those outside predicted CDSs with their respective frequencies, and the table below
corresponds to the gene’s functional region in the phage genome, phage type and the consensus Protospacer Adjacent Motifs (PAMs) detected
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were used as a reference set for the identified of similar
MGEs by BLASTn. Whole genome alignment and single
nucleotide differences were generated using MAUVE
v.2.4.0 [83]. Average nucleotide identity was calculated fol-
lowing the method described in [38], using the online web
based tool which can be accessed at http://enve-omics.ce.
gatech.edu/ani/ with parameters of min. length 700 bp,
min. identity 70% and min. alignment 50. Dotplot analysis
was generated using Gepard [72]. Genome comparison
maps were generated using EasyFig v.2.2.2 [84]. Restriction
Fig. 4 CRISPR spacer content with perfect matches to C. difficile isolate genomes. The spacer sequences from the 6 CRISPR arrays (on y axis).
Protospacer locations (x axis) are shown in first column from perfect and imperfect matches for annotation (details in figure key). The next 53
columns contain perfect matches between spacers and corresponding C. difficile bacterial isolate sequences, coloured according to protospacer
location (see key). The protospacer locations include those in conserved prophage genes. A total of 201 perfect matches were identified, with the
spacer with most protospacers (n = 39) identified for CRISPR_2_17, in a phage protein of unknown function
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modification systems were analysed using entries from
REBASE (the Restriction Enzyme database) [58]. Prophage
regions were predicted using PHAST [85]. CRISPR arrays
were identified using CRISPRfinder [86], and the genomes
CRISPR content compared using CRISPRcompar [87].
Spacer sequences were searched against the GenBank-
Phage, RefSeq-Plasmid, RefSeq-Viral and Genbank-
Environmental databases (accessed 1/10/2015) using
CRISPRTarget [67] in addition to virus metagenome data-
sets (Additional file 5: Table S4). Spacer protein targets
were identified using a curated approach based on annota-
tions on the NCBI genome browser at locations identified
from the CRISPRTarget search. Where no annotation was
available from perfect spacer-target matches on CRISPR-
Target, consensus annotations from imperfect matches (up
to 7 mismatches) were used.
Additional files
Additional file 1: Table S1. In silico ribotype profiles for the C. difficile
genomes. (DOCX 12 kb)
Additional file 2: Table S2. Novel transposon sequence similarity in
C. difficile strains. (DOCX 12 kb)
Additional file 3: Table S5. CRISPR spacer matches to C. difficile
genomic sequences. (DOCX 27 kb)
Additional file 4: Table S3. Genome sequences used in this study.
(DOCX 13 kb)
Additional file 5: Table S4. Viral metagenome datasets used for
protospacer identification. (DOCX 13 kb)
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